rs587777852
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PP5_Very_Strong
The ENST00000350721.9(ATR):c.6897+464C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000088 in 170,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000053 ( 0 hom. )
Consequence
ATR
ENST00000350721.9 intron
ENST00000350721.9 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0550
Genes affected
ATR (HGNC:882): (ATR serine/threonine kinase) The protein encoded by this gene is a serine/threonine kinase and DNA damage sensor, activating cell cycle checkpoint signaling upon DNA stress. The encoded protein can phosphorylate and activate several proteins involved in the inhibition of DNA replication and mitosis, and can promote DNA repair, recombination, and apoptosis. This protein is also important for fragile site stability and centrosome duplication. Defects in this gene are a cause of Seckel syndrome 1. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PP5
Variant 3-142465860-G-C is Pathogenic according to our data. Variant chr3-142465860-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 156537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATR | NM_001184.4 | c.6897+464C>G | intron_variant | ENST00000350721.9 | NP_001175.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATR | ENST00000350721.9 | c.6897+464C>G | intron_variant | 1 | NM_001184.4 | ENSP00000343741 | P1 | |||
ENST00000460977.1 | n.269-49C>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151840Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
14
AN:
151840
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000535 AC: 1AN: 18700Hom.: 0 Cov.: 0 AF XY: 0.0000974 AC XY: 1AN XY: 10264
GnomAD4 exome
AF:
AC:
1
AN:
18700
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
10264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151840Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74182
GnomAD4 genome
AF:
AC:
14
AN:
151840
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74182
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | ATR: PM3, PS3:Moderate, PM2:Supporting, PP3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change falls in intron 40 of the ATR gene. It does not directly change the encoded amino acid sequence of the ATR protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs587777852, gnomAD 0.007%). This variant has been observed in individuals with Seckel syndrome (PMID: 23144622). ClinVar contains an entry for this variant (Variation ID: 156537). Studies have shown that this variant alters ATR gene expression (PMID: 23144622). Studies have shown that this variant results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 23144622). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
ATR-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 02, 2024 | The ATR c.6897+464C>G variant is predicted to interfere with splicing. This variant has been reported with a second ATR variant in two individuals with Seckel syndrome (Ogi et al. 2012. PubMed ID: 23144622). RT-PCR studies suggest this variant impacts mRNA splicing (Ogi et al. 2012. PubMed ID: 23144622). This variant is reported in 0.013% of alleles in individuals of European (non-Finnish) descent in gnomAD and is reported as pathogenic/likely pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/156537/). We interpret this variant as likely pathogenic. - |
Seckel syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2012 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at